UNITED STATES DISTRICT COURT CENTRAL DISTRICT OF CALIFORNIA
JOHN DOE, on behalf of himself CV 23-870 DSF (JPRx) and all others similarly situated, Plaintiff, Order GRANTING Motion to Remand (Dkt. 13) v.
CEDARS-SINAI HEALTH SYSTEM, et al., Defendants.
Plaintiff John Doe moves to remand this action to the Superior Court of California, County of Los Angeles. Dkt. 13 (Mot.). Defendants Cedars-Sinai Health System and Cedars-Sinai Medical Center (collectively Cedars-Sinai) oppose. Dkt. 17 (Opp’n). The Court deems this matter appropriate for decision without oral argument. See Fed. R. Civ. P. 78; Local Rule 7-15. I. BACKGROUND On December 30, 2022, Plaintiff John Doe filed a class action lawsuit on behalf of himself and all others similarly situated, alleging that Cedars-Sinai disclosed their private information, without their knowledge or consent, to Meta, Google, Microsoft Bing, and other marketing and social medial platforms or businesses. See Dkt. 1-1, Ex. A at 3 (Compl.). Doe alleges that Cedars-Sinai transmitted portions of patients’ private communications with it through tracking code embedded in its website and mobile application, to third parties for the sole purpose of sharing such information with marketing entities. Id. ¶¶ 1, 4. Cedars-Sinai installed the tracking code to obtain insight about how patients and potential patients use its website. Id. ¶ 5. Moreover, “[b]y installing the tracking code . . . Cedars-Sinai enabled the marketing entities to use patients’ Private Information to target them with advertising by yet other, unrelated businesses.” Id. ¶ 6. Doe asserts the following causes of action: (1) violations of California’s Invasion of Privacy Act, Cal. Penal Code §§ 630, et seq.; (2) invasion of privacy in violation of the California Constitution, Article 1, § 1 and California common law; (3) breach of implied contract; (4) breach of contract; (5) breach of implied covenant of good faith and fair dealing; (6) negligence; (7) violation of California’s Confidentiality of Medical Information Act, Cal. Civ. Code §§ 56, et seq.; and (8) violation of the California UCL, Cal. Bus. & Prof. Code §§ 17200, et seq. Id. ¶¶ 140-238. On February 3, 2023, Cedars-Sinai removed the case pursuant to 28 U.S.C. § 1442(a)(1), the federal officer removal statute. See Dkt. 1. II. LEGAL STANDARD A defendant may remove to federal court a state court action brought against the “United States or any agency thereof or any officer (or any person acting under that officer) of the United States or of any agency thereof, sued in an official or individual capacity for any act under color of such office . . . .” 28 U.S.C. § 1442(a)(1); Watson v. Philip Morris Cos., Inc., 551 U.S. 142, 145 (2007). Federal officer removal is available under 28 U.S.C. § 1442(a) if “(a) [the removing party] is a ‘person’ within the meaning of the statute; (b) there is a causal nexus between its actions, taken pursuant to a federal officer’s directions, and plaintiff’s claims; and (c) it can assert a ‘colorable federal defense.’” Fidelitad, Inc. v. Insitu, Inc., 904 F.3d 1095, 1099 (9th Cir. 2018). III. DISCUSSION1 Cedars-Sinai asserts that “[o]ver the past two decades, the federal government has engaged in an extensive effort to build a nationwide health information technology infrastructure,” and this case challenges the legitimacy of actions Cedars-Sinai “has taken in connection with pursuing that directive.” Dkt. 1 at 1. Cedars-Sinai contends that it has dutifully assisted and followed the federal government’s direction as part of a public-private initiative to develop a nationwide infrastructure for health information technology, and in doing so, “has acted within the penumbra of federal action and office.” Id. at 4. Cedars-Sinai argues that it qualifies as a “person” under the statute and has acted under a federal officer. Id. at 7-10. Cedars-Sinai explains that the Office of the National Health Coordinator for Health Information Technology (ONC) published guidance for private providers to follow, including a five-year strategic plan that dictated that federal agencies were to collaborate with private stakeholders to build a culture of electronic health information access and use. Id. at 5. One aspect of the strategy was the Centers for Medicare & Medicaid Services’ (CMS) Meaningful Use Program (MUP), which is aimed at increasing patients’ meaningful use and engagement with electronic health records through the creation of patient portals. Id. at 6. Under the program, “providers must meet certain criteria to receive full Medicare reimbursement, one of which is having an interoperable patient portal.” Id. Cedars-Sinai asserts that it is acting under a federal officer because the federal government incentivizes, regulates, monitors, and supervises its actions as part of the MUP “in order to meet the federal government’s national priority of interoperable health information technology,” and Cedars-Sinai is helping the government produce the “nationwide, interoperable information technology infrastructure for health information.” Id. at 8. Cedars-Sinai also contends that in the
1 The Court GRANTS Cedar-Sinai’s unopposed request for judicial notice. See Dkt. 18 at 4 absence of its actions, the government “would be left alone to complete its mission,” that the government has specified how to best enhance patient engagement, including through a patient portal, and that the government has created an office dedicated to this issue and has closely monitored the work of private entities like Cedars-Sinai. Id. at 8-9. Doe argues that the case should be remanded to state court because Cedars-Sinai has not met its burden of establishing that its actions were taken pursuant to a federal officer’s directions. Mot. at 1. He argues that Cedars-Sinai is not acting on behalf of a federal officer in a manner akin to an agency relationship because “merely ‘performing some functions that a government agency controls is not enough to transform a private entity into a federal officer.’” Id. at 6 (citing Romeo v. Canoga Healthcare, Inc., No. CV 21-02918-AB (RAOx), 2021 WL 3418730, at *2 (C.D. Cal. Aug. 5, 2021)). He contends that nothing in Cedars-Sinai’s notice of removal indicates it was authorized to act for or in place of the federal government or that the federal government delegated its authority to Cedars-Sinai to act on its behalf. Id. at 7. Doe also argues that Cedars-Sinai’s pursuit of full Medicare reimbursement through the MUP does not qualify “as acting under the subjection, guidance, or control of the officer,” nor does it place Cedars- Sinai in “a relationship which ‘is an unusually close one involving detailed regulation, monitoring, or supervision.’” Id. at 8 (citing Cnty. of San Mateo v. Chevron Corp., 32 F.4th 733, 756 (9th Cir. 2022)). Cedars-Sinai asserts in opposition that it assisted the federal government in carrying out a federal directive by increasing web traffic to its website, which contains a link to a patient portal. Opp’n at 6. It asserts that its “alleged efforts were in furtherance of implementing the federal government’s goal” and are sufficient to effectuate removal to this Court. Id.
Free access — add to your briefcase to read the full text and ask questions with AI
UNITED STATES DISTRICT COURT CENTRAL DISTRICT OF CALIFORNIA
JOHN DOE, on behalf of himself CV 23-870 DSF (JPRx) and all others similarly situated, Plaintiff, Order GRANTING Motion to Remand (Dkt. 13) v.
CEDARS-SINAI HEALTH SYSTEM, et al., Defendants.
Plaintiff John Doe moves to remand this action to the Superior Court of California, County of Los Angeles. Dkt. 13 (Mot.). Defendants Cedars-Sinai Health System and Cedars-Sinai Medical Center (collectively Cedars-Sinai) oppose. Dkt. 17 (Opp’n). The Court deems this matter appropriate for decision without oral argument. See Fed. R. Civ. P. 78; Local Rule 7-15. I. BACKGROUND On December 30, 2022, Plaintiff John Doe filed a class action lawsuit on behalf of himself and all others similarly situated, alleging that Cedars-Sinai disclosed their private information, without their knowledge or consent, to Meta, Google, Microsoft Bing, and other marketing and social medial platforms or businesses. See Dkt. 1-1, Ex. A at 3 (Compl.). Doe alleges that Cedars-Sinai transmitted portions of patients’ private communications with it through tracking code embedded in its website and mobile application, to third parties for the sole purpose of sharing such information with marketing entities. Id. ¶¶ 1, 4. Cedars-Sinai installed the tracking code to obtain insight about how patients and potential patients use its website. Id. ¶ 5. Moreover, “[b]y installing the tracking code . . . Cedars-Sinai enabled the marketing entities to use patients’ Private Information to target them with advertising by yet other, unrelated businesses.” Id. ¶ 6. Doe asserts the following causes of action: (1) violations of California’s Invasion of Privacy Act, Cal. Penal Code §§ 630, et seq.; (2) invasion of privacy in violation of the California Constitution, Article 1, § 1 and California common law; (3) breach of implied contract; (4) breach of contract; (5) breach of implied covenant of good faith and fair dealing; (6) negligence; (7) violation of California’s Confidentiality of Medical Information Act, Cal. Civ. Code §§ 56, et seq.; and (8) violation of the California UCL, Cal. Bus. & Prof. Code §§ 17200, et seq. Id. ¶¶ 140-238. On February 3, 2023, Cedars-Sinai removed the case pursuant to 28 U.S.C. § 1442(a)(1), the federal officer removal statute. See Dkt. 1. II. LEGAL STANDARD A defendant may remove to federal court a state court action brought against the “United States or any agency thereof or any officer (or any person acting under that officer) of the United States or of any agency thereof, sued in an official or individual capacity for any act under color of such office . . . .” 28 U.S.C. § 1442(a)(1); Watson v. Philip Morris Cos., Inc., 551 U.S. 142, 145 (2007). Federal officer removal is available under 28 U.S.C. § 1442(a) if “(a) [the removing party] is a ‘person’ within the meaning of the statute; (b) there is a causal nexus between its actions, taken pursuant to a federal officer’s directions, and plaintiff’s claims; and (c) it can assert a ‘colorable federal defense.’” Fidelitad, Inc. v. Insitu, Inc., 904 F.3d 1095, 1099 (9th Cir. 2018). III. DISCUSSION1 Cedars-Sinai asserts that “[o]ver the past two decades, the federal government has engaged in an extensive effort to build a nationwide health information technology infrastructure,” and this case challenges the legitimacy of actions Cedars-Sinai “has taken in connection with pursuing that directive.” Dkt. 1 at 1. Cedars-Sinai contends that it has dutifully assisted and followed the federal government’s direction as part of a public-private initiative to develop a nationwide infrastructure for health information technology, and in doing so, “has acted within the penumbra of federal action and office.” Id. at 4. Cedars-Sinai argues that it qualifies as a “person” under the statute and has acted under a federal officer. Id. at 7-10. Cedars-Sinai explains that the Office of the National Health Coordinator for Health Information Technology (ONC) published guidance for private providers to follow, including a five-year strategic plan that dictated that federal agencies were to collaborate with private stakeholders to build a culture of electronic health information access and use. Id. at 5. One aspect of the strategy was the Centers for Medicare & Medicaid Services’ (CMS) Meaningful Use Program (MUP), which is aimed at increasing patients’ meaningful use and engagement with electronic health records through the creation of patient portals. Id. at 6. Under the program, “providers must meet certain criteria to receive full Medicare reimbursement, one of which is having an interoperable patient portal.” Id. Cedars-Sinai asserts that it is acting under a federal officer because the federal government incentivizes, regulates, monitors, and supervises its actions as part of the MUP “in order to meet the federal government’s national priority of interoperable health information technology,” and Cedars-Sinai is helping the government produce the “nationwide, interoperable information technology infrastructure for health information.” Id. at 8. Cedars-Sinai also contends that in the
1 The Court GRANTS Cedar-Sinai’s unopposed request for judicial notice. See Dkt. 18 at 4 absence of its actions, the government “would be left alone to complete its mission,” that the government has specified how to best enhance patient engagement, including through a patient portal, and that the government has created an office dedicated to this issue and has closely monitored the work of private entities like Cedars-Sinai. Id. at 8-9. Doe argues that the case should be remanded to state court because Cedars-Sinai has not met its burden of establishing that its actions were taken pursuant to a federal officer’s directions. Mot. at 1. He argues that Cedars-Sinai is not acting on behalf of a federal officer in a manner akin to an agency relationship because “merely ‘performing some functions that a government agency controls is not enough to transform a private entity into a federal officer.’” Id. at 6 (citing Romeo v. Canoga Healthcare, Inc., No. CV 21-02918-AB (RAOx), 2021 WL 3418730, at *2 (C.D. Cal. Aug. 5, 2021)). He contends that nothing in Cedars-Sinai’s notice of removal indicates it was authorized to act for or in place of the federal government or that the federal government delegated its authority to Cedars-Sinai to act on its behalf. Id. at 7. Doe also argues that Cedars-Sinai’s pursuit of full Medicare reimbursement through the MUP does not qualify “as acting under the subjection, guidance, or control of the officer,” nor does it place Cedars- Sinai in “a relationship which ‘is an unusually close one involving detailed regulation, monitoring, or supervision.’” Id. at 8 (citing Cnty. of San Mateo v. Chevron Corp., 32 F.4th 733, 756 (9th Cir. 2022)). Cedars-Sinai asserts in opposition that it assisted the federal government in carrying out a federal directive by increasing web traffic to its website, which contains a link to a patient portal. Opp’n at 6. It asserts that its “alleged efforts were in furtherance of implementing the federal government’s goal” and are sufficient to effectuate removal to this Court. Id. Cedars-Sinai also asserts that it gave patients the opportunity to access their personal electronic health records with Cedars-Sinai through a My CS-Link patient portal and submitted reports on its involvement in the MUP to CMS. Id. at 11-12. The Court agrees with Doe. The Supreme Court has “interpreted the term ‘person acting under that officer’ as extending to a ‘private person’ who has certain types of close relationships with the federal government.” Cnty. of San Mateo, 32 F.4th at 756 (9th Cir. 2022) (citing Watson, 551 U.S. at 152-53). “The Supreme Court has identified a number of factors courts should consider in determining whether a private person is acting under a federal officer for purposes of § 1442(a)(1).” Id. The Court considers: (1) “whether the person is acting on behalf of the officer in a manner akin to an agency relationship”; (2) “whether the person is subject to the officer’s close direction, such as acting under the subjection, guidance, or control of the officer, or in a relationship which is an unusually close one involving detailed regulation, monitoring, or supervision”; (3) “whether the private person is assisting the federal officer in fulfilling basic governmental tasks that the Government itself would have had to perform if it had not contracted with a private firm”; and (4) “whether the private person’s activity is so closely related to the government’s implementation of its federal duties that the private person faces a significant risk of state- court ‘prejudice, just as a government employee would in similar circumstances, and may have difficulty in raising an immunity defense in state court.” Id. at 756-57 (internal quotation marks and citations omitted). However, “[a] private firm’s compliance (or noncompliance) with federal laws, rules, and regulations does not by itself fall within the scope of the statutory phrase ‘acting under’ a federal ‘official.’ And that is so even if the regulation is highly detailed and even if the private firm’s activities are highly supervised and monitored.” Watson, 551 U.S. at 153. Courts “may not interpret § 1442(a) so as to ‘expand the scope of the statute considerably, potentially bringing within its scope state-court actions filed against private firms in many highly regulated industries.’” Cnty. of San Mateo, 32 F.4th at 757 (quoting Watson, 551 U.S. at 153). The directions Cedars-Sinai points to are general regulations and public directives regarding the development of health information technology and an electronic health records infrastructure. Therefore, removal is not justified by federal officer jurisdiction. IV. CONCLUSION The motion to remand is GRANTED. The case is REMANDED to the Superior Court of California, County of Los Angeles. IT IS SO ORDERED.
fy Date: April 24, 2023 Kile A. JercAw Dale S. Fischer United States District Judge